Showing 121 to 132 of 171 results
Pfizer Q4 Earnings Beat Expectations Amidst Covid Revenue Decline and Cost-Cutting Success
Pfizer's Q4 2024 earnings beat analysts' estimates, reporting adjusted EPS of $0.63 and revenue of $17.76 billion, exceeding expectations due to strong Covid product sales and cost reductions; however, future challenges remain due to the Inflation Reduction Act's impact and market competition.
Pfizer Q4 Earnings Beat Expectations Amidst Covid Revenue Decline and Cost-Cutting Success
Pfizer's Q4 2024 earnings beat analysts' estimates, reporting adjusted EPS of $0.63 and revenue of $17.76 billion, exceeding expectations due to strong Covid product sales and cost reductions; however, future challenges remain due to the Inflation Reduction Act's impact and market competition.
Progress
40% Bias Score
Addressing Employee Mental Health Challenges Through Digital Solutions
Rising healthcare costs and persistent employee mental health challenges (74% moderate stress, 38% high stress, 60% burnout) necessitate new, cost-effective digital solutions tailored to underserved populations, personalized, evidence-based, compelling, and integrated with existing resources.
Addressing Employee Mental Health Challenges Through Digital Solutions
Rising healthcare costs and persistent employee mental health challenges (74% moderate stress, 38% high stress, 60% burnout) necessitate new, cost-effective digital solutions tailored to underserved populations, personalized, evidence-based, compelling, and integrated with existing resources.
Progress
44% Bias Score
French Life Expectancy Increases, but Inequalities Remain
A 2024 report by Drees shows that French life expectancy increased, exceeding 2019 levels, with women at 85.7 years and men at 80 years; healthy life expectancy at 65 also rose significantly, but inequalities persist.
French Life Expectancy Increases, but Inequalities Remain
A 2024 report by Drees shows that French life expectancy increased, exceeding 2019 levels, with women at 85.7 years and men at 80 years; healthy life expectancy at 65 also rose significantly, but inequalities persist.
Progress
32% Bias Score
COVID-19 Drives Surge in Australian Private Hospital Costs
Australia's Private Health Association's 2023 report reveals an 8.6% increase in high hospital claims (\$10,000+), largely due to COVID-19 and long COVID, with some patients incurring costs exceeding \$190,000 for extended stays; this impacts private health insurance premiums.
COVID-19 Drives Surge in Australian Private Hospital Costs
Australia's Private Health Association's 2023 report reveals an 8.6% increase in high hospital claims (\$10,000+), largely due to COVID-19 and long COVID, with some patients incurring costs exceeding \$190,000 for extended stays; this impacts private health insurance premiums.
Progress
56% Bias Score
Self-Insured Patients Pay More for Endoscopies
The cost of an endoscopy ranges from \$1200 to \$5000, depending on insurance negotiations; self-insured patients often pay 8% more due to their employers' weaker bargaining position compared to large insurance companies.
Self-Insured Patients Pay More for Endoscopies
The cost of an endoscopy ranges from \$1200 to \$5000, depending on insurance negotiations; self-insured patients often pay 8% more due to their employers' weaker bargaining position compared to large insurance companies.
Progress
48% Bias Score
FTC Accuses PBMs of \$8.7 Billion in Price Gouging
The FTC released a report accusing the three largest Pharmacy Benefit Managers (PBMs)—OptumRx, Express Scripts, and CVS Caremark—of marking up specialty generic drug prices by over \$7.3 billion from 2017-2022, and an additional \$1.4 billion through spread pricing, ultimately increasing patient cos...
FTC Accuses PBMs of \$8.7 Billion in Price Gouging
The FTC released a report accusing the three largest Pharmacy Benefit Managers (PBMs)—OptumRx, Express Scripts, and CVS Caremark—of marking up specialty generic drug prices by over \$7.3 billion from 2017-2022, and an additional \$1.4 billion through spread pricing, ultimately increasing patient cos...
Progress
24% Bias Score
GLP-1 Drug Adherence: Cost, Side Effects, and Income Disparities
A JAMA Network Open study reveals that 65% of patients without diabetes stopped using GLP-1 weight loss drugs within a year, compared to 46% of those with Type 2 diabetes; side effects and cost were the main reasons, while higher income and weight loss correlated with continued use; Noom's layoffs e...
GLP-1 Drug Adherence: Cost, Side Effects, and Income Disparities
A JAMA Network Open study reveals that 65% of patients without diabetes stopped using GLP-1 weight loss drugs within a year, compared to 46% of those with Type 2 diabetes; side effects and cost were the main reasons, while higher income and weight loss correlated with continued use; Noom's layoffs e...
Progress
40% Bias Score
Rising Cancer Rates Drive Employer Focus on Holistic Employee Support
The American Cancer Society predicts over 2 million new cancer cases in 2024, leading to increased healthcare costs; employers are responding by improving access to mental and physical healthcare, including programs like Calm Health's Tools to Cope with Cancer, which has a 4 out of 5 user rating.
Rising Cancer Rates Drive Employer Focus on Holistic Employee Support
The American Cancer Society predicts over 2 million new cancer cases in 2024, leading to increased healthcare costs; employers are responding by improving access to mental and physical healthcare, including programs like Calm Health's Tools to Cope with Cancer, which has a 4 out of 5 user rating.
Progress
36% Bias Score
Soaring Demand for Expensive Weight-Loss Drugs in the Netherlands
The number of Dutch citizens purchasing costly new weight-loss drugs increased dramatically from 2000 prescriptions in 2022 to 109,000 in 2023, raising concerns about accessibility and the strain on the healthcare system due to high costs and potential exacerbation of health inequalities.
Soaring Demand for Expensive Weight-Loss Drugs in the Netherlands
The number of Dutch citizens purchasing costly new weight-loss drugs increased dramatically from 2000 prescriptions in 2022 to 109,000 in 2023, raising concerns about accessibility and the strain on the healthcare system due to high costs and potential exacerbation of health inequalities.
Progress
52% Bias Score
Elevance Health Profits Halved Despite Overall Revenue Growth
Elevance Health reported $5.98 billion in 2024 profits, but its fourth-quarter net income dropped to $418 million due to a 320 basis point increase in its benefit expense ratio to 92.4 percent, largely because of higher medical costs from Medicaid patients and the end of the public health emergency.
Elevance Health Profits Halved Despite Overall Revenue Growth
Elevance Health reported $5.98 billion in 2024 profits, but its fourth-quarter net income dropped to $418 million due to a 320 basis point increase in its benefit expense ratio to 92.4 percent, largely because of higher medical costs from Medicaid patients and the end of the public health emergency.
Progress
32% Bias Score
Rising Costs of Long-Term Health Insurance in Greece
In 2023, Greek long-term health insurance policies (255,000, 25% of market) showed a 19.5% claim frequency, averaging €4,560 per claim – up from 17.8% and €4,370 in 2022, driven by complex medical procedures and technological advancements, necessitating premium adjustments while protecting policyhol...
Rising Costs of Long-Term Health Insurance in Greece
In 2023, Greek long-term health insurance policies (255,000, 25% of market) showed a 19.5% claim frequency, averaging €4,560 per claim – up from 17.8% and €4,370 in 2022, driven by complex medical procedures and technological advancements, necessitating premium adjustments while protecting policyhol...
Progress
32% Bias Score
Erasmus MC Parking Fee Hike Spurs Outrage
Erasmus MC in Rotterdam increased parking fees in January 2024, leading to complaints from patients and visitors who face increased costs, especially those needing frequent hospital visits; the hospital cited limited parking and the need to prevent use by non-hospital visitors.
Erasmus MC Parking Fee Hike Spurs Outrage
Erasmus MC in Rotterdam increased parking fees in January 2024, leading to complaints from patients and visitors who face increased costs, especially those needing frequent hospital visits; the hospital cited limited parking and the need to prevent use by non-hospital visitors.
Progress
48% Bias Score
Showing 121 to 132 of 171 results